Weight loss injections like Wegovy and Mounjaro, initially developed to address diabetes, are now being utilized by 2.4 million individuals in the UK. These injections are being celebrated by experts as revolutionary drugs that can help individuals shed up to a fifth of their body weight. Additionally, they have shown promise in potentially preventing heart attacks, cancer, and aiding in addressing addiction and depression.
While these drugs, which imitate the hormone glucagon-like peptide 1 (GLP-1) to reduce appetite, are deemed safe for NHS use, emerging evidence suggests possible side effects. Recent research has indicated a potential connection between weight-loss injections and hair loss, coupled with reported issues of vomiting and diarrhea among patients.
It is essential to monitor for side effects related to sudden dietary changes. A consensus statement from top obesity experts highlighted the importance of maintaining a balanced diet with adequate protein intake for users of GLP-1 drugs. Additionally, recent studies have suggested a link between weight loss injections and hair loss, potentially attributed to calorie intake fluctuations and nutrient deficiencies.
Common side effects of weight loss injections include nausea, vomiting, diarrhea, and constipation. Severe side effects such as gallbladder removal and acute pancreatitis have also been reported. Users are advised to stay hydrated and seek medical advice if experiencing adverse effects.
Furthermore, weight loss injections may lead to muscle and bone density loss, emphasizing the importance of incorporating exercise while on these medications. The NHS recommends a balanced diet, regular physical activity, and personalized support services for individuals using weight loss drugs.
Despite the positive impact on weight loss, it is crucial to address potential side effects and long-term sustainability when using weight-loss injections. The availability of these drugs through the NHS is currently limited to individuals with severe obesity and other associated health issues. Efforts are ongoing to ensure access to these medications for those in need.